Financhill
Buy
69

NEPH Quote, Financials, Valuation and Earnings

Last price:
$5.58
Seasonality move :
-4.94%
Day range:
$5.54 - $5.97
52-week range:
$1.39 - $6.42
Dividend yield:
0%
P/E ratio:
40.91x
P/S ratio:
3.39x
P/B ratio:
6.00x
Volume:
28.4K
Avg. volume:
73.4K
1-year change:
248.77%
Market cap:
$60M
Revenue:
$14.2M
EPS (TTM):
$0.14

Earnings Data

Next earnings date for NEPH
Mar 05
2026
Most recent earnings per share
$0.03
Beat by $0.05
(Nov 6/2025)
Consensus Estimate
-$0.02
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NEPH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 $4.5M -- -- $0.01 --
11/06/2025 Q3 $3.9M $4.8M $0.03 -$0.02 $0.05
08/07/2025 Q2 $3.6M $4.4M $0.02 -$0.03 $0.05
05/08/2025 Q1 $3.7M $4.9M $0.05 -$0.01 $0.06
03/06/2025 Q4 $3.6M $3.9M $0.03 -$0.02 $0.05
11/07/2024 Q3 $3.5M $3.5M $0.02 -$0.02 $0.04
08/08/2024 Q2 $3.9M $3.3M -$0.03 -$0.02 -$0.01
05/09/2024 Q1 $3.7M $3.5M -$0.02 -$0.04 $0.02
03/07/2024 Q4 $3.8M $3.3M -$0.06 -$0.03 -$0.04
11/08/2023 Q3 $3.4M $3.7M -$0.02 -$0.05 $0.03
08/10/2023 Q2 $3.1M $3.5M -$0.04 -$0.06 $0.01
05/04/2023 Q1 -- $3.7M -$0.03 -- --
02/23/2023 Q4 -- $2.6M -$0.09 -- --
11/04/2022 Q3 -- $2.4M -$0.31 -- --
08/10/2022 Q2 -- $2.9M -$0.12 -- --
05/04/2022 Q1 -- $2.2M -$0.20 -- --
02/23/2022 Q4 -- $2.7M -$0.11 -- --
11/04/2021 Q3 -- $2.6M -$0.12 -- --
08/05/2021 Q2 -- $2.3M -$0.12 -- --
05/06/2021 Q1 -- $2.7M -$0.06 -- --
03/01/2021 Q4 -- $2.3M -$0.08 -- --
11/05/2020 Q3 -- $2.1M -$0.12 -- --
08/05/2020 Q2 -- $1.6M -$0.19 -- --
05/06/2020 Q1 -- $2.5M -$0.13 -- --
02/27/2020 Q4 -- $3.2M -$0.03 -- --
11/06/2019 Q3 -- $3.1M -$0.10 -- --
08/07/2019 Q2 -- $2.3M -$0.14 -- --
03/31/2019 Q1 -- $1.8M -$0.20 -- --
12/31/2018 Q4 -- $1.6M -$0.10 -- --
09/30/2018 Q3 -- $1.7M -$0.08 -- --
06/30/2018 Q2 -- $1.4M -$0.10 -- --
03/31/2018 Q1 -- $985K -$0.23 -- --
12/31/2017 Q4 -- $1.3M $0.21 -- --
09/30/2017 Q3 -- $916K -$0.11 -- --
06/30/2017 Q2 -- $859K -$0.13 -- --
03/31/2017 Q1 -- $734K -$0.12 -- --
12/31/2016 Q4 -- $745K -$0.09 -- --
09/30/2016 Q3 -- $475K -$0.09 -- --
06/30/2016 Q2 -- $509K -$0.18 -- --
03/31/2016 Q1 -- $590K -$0.18 -- --
12/31/2015 Q4 -- $511K -$0.18 -- --

Nephros, Inc. Earnings Questions

  • How Much did Nephros, Inc. Generate in Revenue Last Quarter?

    Nephros, Inc. reported $4.8M worth of top line sales in its most recent quarter.

  • Did Nephros, Inc. Beat Earnings Last Quarter?

    Nephros, Inc. announced earnings per share of $0.03 which represents a beat of analyst forecast a -$0.02 per share.

  • Is Nephros, Inc. Profitable?

    Nephros, Inc. reported $2.9M that represents $0.26 per share over the last quarter.

  • What is the Analyst Consensus for Nephros, Inc. EPS Next Year?

    Nephros, Inc.'s earnings are forecast to grow from $0.01 per share to -$0.04 per share next year representing an increase of 1471.43%.

  • When is Nephros, Inc.'s Earnings Date?

    Nephros, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 31.68% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 45.78% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 8.15% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock